Skip Navigation
 

EVENTS

Our meetings provide a national forum for leaders in the field to explore and discuss priorities, challenges, and policy implications in health security.

Congressional Seminar Series

3rd Congressional Seminar:
Considerations for the 2012 Reauthorization of PAHPA


Overview

On March 1, 2012, the Center for Biosecurity of UPMC and the Biotechnology Industry Organization (BIO) convened Congressional staff, government officials, biosecurity organizations, and key stakeholders to discuss the importance of reauthorizing the Pandemic and All-Hazards Preparedness Act (PAHPA). With a standing room only audience of more than 100 attendees, the response to this issue was impressive, with significant numbers of both Congressional staff and members of the biosecurity community at large in attendance for a lively, informative meeting.

Learn more about PAHPA: http://www.phe.gov/preparedness/legal/pahpa/pages/default.aspx


More Events in the Center for Biosecurity Congressional Seminar Series

The series honorary co-host is the Senate Caucus on WMD Terrorisim




Agenda

Welcome and Introductions

  • Scott Whitaker, Chief Operating Officer, Biotechnology Industry Organization (BIO)

Opening Remarks

  • Senator Robert P. Casey, Jr., US Senator, Pennsylvania

  • Congressman Mike Rogers, US Representative for Michigan's 8th Congressional District

Panel 1: Biological Threats and Current Challenges

  • Robert Kadlec, Former Special Assistant to the President for Homeland Security and Senior Director for Biological Defense Policy; Vice President, PRTM, Moderator

  • Philip K. Russell, Former Senior Advisor, Office of the Assistant Secretary for Public Health Emergency Preparedness, US Department of Health and Human Services

  • Lynne Kidder, President, The WMD Center

Panel 2: The Importance of Reauthorizing PAHPA

  • Tom Inglesby, CEO and Director, Center for Biosecurity of UPMC, Moderator

  • Brian Kamoie, Senior Director for Preparedness Policy, National Security Staff, Executive Office of the President

  • Ali Khan, Director, Office of Public Health Preparedness and Response, US Centers for Disease Control and Prevention

  • Richard Hatchett, Chief Medical Officer and Deputy Director for Strategic Sciences, Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), US Department of Health and Human Services

  • Jesse Goodman, Chief Scientist, Office of the Chief Scientist, U.S. Food and Drug Administration (FDA)

Closing Remarks

  • Tom Inglesby, CEO and Director, Center for Biosecurity of UPMC



Speakers
 

Senator Casey photo
Robert "Bob" Casey, Jr.
U.S. Senator, Pennsylvania
 
Richard Hatchett
Richard Hatchett
Chief Medical Officer and Deputy Director for Strategic Sciences, BARDA, ASPR, HHS
 
Dr. Robert Kadlec
Robert Kadlec
Former Special Assistant to the President for Homeland Security and Senior Director for Biological Defense Policy
 
Brian Kamoie
Brian Kamoie
Senior Director for Preparedness Policy, National Security Staff, Executive Office of the President
 
Lynn Kidder
Lynn Kidder
President, The WMD Center
 
Dr. Ali Khan
Ali Khan
Director, Office of Public Health Preparedness and Response, CDC
 
Dr. Tom Inglesby
Tom Inglesby
CEO and Director, Center for Biosecurity of UPMC
 
Representative Mike Rogers
Mike Rogers
U.S. Representative for Michigan's 8th Congressional District
 
Phillip K. Russell
Philip K. Russell
Former Senior Advisor, Office of the Assistant Secretary for Public Health Emergency Preparedness, HHS
 
Phillip K. Russell
Scott Whitaker
Chief Operating Officer, Biotechnology Industry Organization (BIO)
 
Phillip K. Russell
Jesse Goodman
Chief Scientist, Office of the Chief Scientist, U.S. Food and Drug Administration (FDA)
 



Conference Photos
 

amesh
Lynn Kidder and Philip K. Russell
image2
L to R: Phyllis Arthur, Richard Hatchett, and Ali Khan
image3
Congressman Mike Rogers
image2
Senator Robert Casey
image1
Rhilip K. Russell